This site is intended for healthcare professionals only
Page Created On : 22 Jan 2022 12:13 PM GMT , Page Last Updated On : 23 Feb 2022 11:55 AM GMT

Company name

JBCPL

Company logo

Image

About

Azovas ( Azelnidipine) is a third-generation calcium channel blocker and is used in the treatment of Hypertension. Azovas is marketed by J.B. Chemicals & Pharmaceuticals Ltd. and comes in two doses namely Azovas 8 mg and Azovas 16 mg.

Azelnidipine is a dihydropyridine calcium channel blocker and is known to be less susceptible to hepatic first-pass effect and its antihypertensive effect is slow sustained. This drug expresses hypotensive action by L-type and T-type Ca+ channel antagonism and blood vessels dilation.

Studies have shown it to besides its slow and sustained hypotensive action, it had little effect on the heart rate compared to similar drugs and was more renal friendly. ( See Product Leaflet).

Headquarters and Address

..

Year of Incorporation

..

Founder/CEO/Key Personnel

..

Leadership Team/Board of Directors

..

Parent Company

...

Subsidiaries

...

Total Number of Employees

..

Financials (Annual Turnover, Profits) – From their annual reports

...

Awards and Recognitions

...

Company’s website

...

Contact Details: WhatsApp, Call, Email

...

Product Categories:

Product Categories: